Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial. 31. Mai 2011 Bartlett, J.M.S., Brookes, C.L., Robson, T., van de Velde, C.J.H., Billingham, L.J., Campbell, F.M., Grant, M., Hasenburg, A., Hille, E.T.M., Kay, C., Kieback, D.G., Putter, H., Markopoulos, C., Kranenbarg, E.M.-K., Mallon, E.A., Dirix, L., Seynaeve, C., Rea, D., 2011. J Clin Oncol 29, 1531–1538. doi:10.1200/JCO.2010.30.3677 Abstract Tumorregister Lymphatische Neoplasien (TLN) der niedergelassenen Hämato-/Onkologen in Deutschland. Abenhardt, W., Knauf, W., 2011. Weiterlesen First line therapy with Bendamustine in advanced indolent Non-Hodgkin Lymphoma in treatment routine – interim analysis of the non-interventional study Be-1st. Becker, M., Tschechne, B., Reeb, M., Schwinger, U., Grass, J., Straßl, L., 2011. Onkologie 34 (suppl.6)(P891), 268. doi:10.1159/000333305 Abstract… Weiterlesen